The need for assays predictive of protection in development of malaria bloodstage vaccines
- 28 February 1997
- journal article
- editorial
- Published by Elsevier in Parasitology Today
- Vol. 13 (2) , 46-47
- https://doi.org/10.1016/s0169-4758(96)20063-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Efficacy trial of malaria vaccine SPf66 in Gambian infantsThe Lancet, 1995
- Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages.The Journal of Experimental Medicine, 1995
- Inhibition of Plasmodium falciparum growth in vitro by CD4+and CD8+T cells from non-exposed donorsParasite Immunology, 1994
- Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern TanzaniaThe Lancet, 1994
- Malaria PathogenesisScience, 1994
- Immunization against malaria with a recombinant proteinParasite Immunology, 1994
- Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaThe Lancet, 1993
- Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparumNature, 1986
- Immunization against blood-stage rodent malaria using purified parasite antigensNature, 1981